Insider · CIK 0001132679
Lawrence Steinman
director
Files at FRMM (ETHZilla Corp), BCAB (BioAtla, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 17, 2025 | FRMM ETHZilla Corp | AGrant or award Common Stock | +44,959 | $0.00 | $0 | 112,493 | Jun 30, 2025 |
| Jun 17, 2025 | FRMM ETHZilla Corp | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +110,000 | $0.00 | $0 | 110,000 | Jun 30, 2025 |
| Jun 17, 2025 | FRMM ETHZilla Corp | AGrant or award Common Stock | +48,198 | $0.00 | $0 | 115,732 | Jun 20, 2025 |
| Jun 17, 2025 | FRMM ETHZilla Corp | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +110,000 | $0.00 | $0 | 110,000 | Jun 20, 2025 |
| Jun 18, 2025 | BCAB BioAtla, Inc. | AGrant or award Common Stock | +23,500 | $0.00 | $0 | 78,459 | Jun 18, 2025 |
| Feb 20, 2025 | FRMM ETHZilla Corp | AGrant or award Common Stock | +65,000 | $0.00 | $0 | 67,534 | Feb 21, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.